National and Kapodistrian University of Athens
Μελέτη των μοριακών διαταραχών του επιγενετικού μηχανισμού ρύθμισης των κυττάρων στην παθογένεια των μυελοϋπερπλαστικών νεοπλασιών
Abstract
dc:description(CNL) and 8/10 (80.00%) in Systemic Mastocytosis (SM). in total 217 out of all MPN patients studied (81.58%), carried at least on driver mutation, whereas only 24 (9.02%) carried modifier mutations, while 44 (16.54%) carried both. However, MF presented the most complicated molecular profile since 42.70% of the respective cases harbored both types of molecular lessions (n=38/89). Non of the genes studied were identified mutated in Chronic Myelogenous Leukemia (CML) patients studied (n=0/29).ii.The same techniques and gene sets were tested for mutations within the 110 patients comprising the MDS/MPN cohort. In total, 91 (82.73%) bearred at least one mutation. The subcohorts were found mutated as follows, 70.18% in CMML (n=40/57), 94.87% in aCML (n=37/39) and 100.00% in MDS/MPN-RS-T (n=14/14). In total, only 15 cases (13.64%) with driver mutations were identified, whereas 69.09% (n=76/110) of MDS/MPN cases presented with at least one modifier mutation. Finally, 11.82% (n=13/110) of MDS/MPN patients studied carried both types of mutations.iii.We designed a custom targeted NGS panel, along with a custom bioinfomratics pipeline, for the interpretation of multiple genomic loci across 26 different genes, of 25 patients. All of them have had their molecular profile checked before, with the utilization of PCR, HRMA and Sanger sequencing. 12 of them were previously found to be bearring at least one mutation, whereas 13 of them had no lessions, whatsoever, according to the afforementioned techniques. The first cohort represented the test group, in order to check the sensitivity and specificity of our NGS protocol. In all 13 patients, those mutations already known were identified during the interpretation of the results, while additional mutations were found in 5 of them. Mutations were spotted in 7 out of the 12 patients without previously undetermined molecular profile.iv.LINEs (Long interspersed nucleotide elements) and SINEs (Short interspersed nucleotide elements), altogether comprise 40-50% of the human genome. Study of methylation of LINE-1 elements is commonly used for the estimation of global DNA methylation levels. The methylation profile of MF and MDS/MPN patients was analyzed for deviations from the respecive levels of normal population. The relative methylation percentage of 15 cases of MDS/MPN and 15 cases of MF, compared to 6 people with normal phenotype and genotype was determined with the utilization of methylation specific HRMA (MS-HRMA). The results were further confirmed with methylation specific pyrosequencing (MSP). 8 patients with MDS/MPN, 28 with MF and 7 people of the general population were tested by using MSP. Data from both techniques coincide. MDS/MPN patients present statistically significant upregulated levels of methylation, whereas the methylation profile of MF patients and normal population is the same.v.Finally, in order to better understand the biology of MF, we performed RNA-Seq in 6 patients presenting with MF and compared their transcription levels with 2 people with normal phenotype and genotype. The bioinformatics pipeline for the analysis of RNA-Seq data is custom and was designed during this study. Statistical analysis identified 2010 genes differentially expressed in MF. Of these 695 were down-regulated, whereas 1315 were up-regulated. The later, correspond to genes related to defence mechanisms against bacterial infections, implicating granulocytes as the main mechanism of action. The down-regulatied genes, on the other hand, imply lymphocyte deactivation, still the mechanism implicated cannot be deciphered by this technique alone and needs to be further studied.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Giannopoulos, Andreas
- Γιαννόπουλος, Ανδρέας
Subjects
dc:subject × 10Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45116